Cargando…
Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant
BACKGROUNDS/AIMS: Salvage liver transplantation (SLT) is a therapeutic strategy for recurrent hepatocellular carcinoma (HCC). However, it remains controversial with compromised survival outcomes and increased perioperative morbidity compared to primary liver transplant (PLT). In the present work, we...
Autores principales: | Guo, Yuxin, Tan, Ek-Khoon, Krishnamoorthy, Thinesh-Lee, Tan, Chee-Kiat, Tan, Ban-Hock, Tan, Thuan-Tong, Lee, Ser-Yee, Chan, Chung-Yip, Cheow, Peng-Chung, Chung, Alexander Y. F., Jeyaraj, Prema Raj, Goh, Brian K. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Hepato-Biliary-Pancreatic Surgery
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405363/ https://www.ncbi.nlm.nih.gov/pubmed/30863801 http://dx.doi.org/10.14701/ahbps.2019.23.1.1 |
Ejemplares similares
-
Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis
por: Guo, Yuxin, et al.
Publicado: (2019) -
Practical Considerations for Solid Organ Transplantation During the COVID-19 Global Outbreak: The Experience from Singapore
por: Chung, Shimin Jasmine, et al.
Publicado: (2020) -
Waitlisted Transplant Candidates’ Attitudes and Concerns Toward Transplantation During COVID-19
por: Tan, Ek Khoon, et al.
Publicado: (2020) -
Liver Transplantation in an Adult with Citrullinaemia Type 2
por: Tan, Hui-Hui, et al.
Publicado: (2011) -
Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure
por: Kumar, Rajneesh, et al.
Publicado: (2015)